
Detanonoate
CAS: 146724-94-9
Ref. 3D-FD16348
1mg | 349,00 € | ||
5mg | 488,00 € | ||
10mg | 695,00 € | ||
25mg | 991,00 € | ||
50mg | 1.489,00 € |
Produktinformation
- 2,2'-(Hydroxynitrosohydrazino)bis-ethanamineNOC-183,3-Bis(aminoethyl)-1-hydroxy-2-oxo-1-triazeneDiethylenetriamine/nitric oxide a dduct
- 1,1-Bis(2-Aminoethyl)-2-Hydroxy-3-Oxotriazane
- 1-Hydroxy-2-Oxo-3,3-Bis(3-Aminoethyl)-1-Triazene
- 2,2'-(2-Hydroxy-3-Oxotriazane-1,1-Diyl)Diethanaminium
- 2,2'-(Hydroxynitrosohydrazino)Bis-Ethamine
- 2,2'-(Hydroxynitrosohydrazino)Bis-Ethanamine
- 2,2′-(2-Hydroxy-2-nitrosohydrazinylidene)bis[ethanamine]
- 3,3-Bis(Aminoethyl)-1-Hydroxy-2-Oxo-1-Triazene
- Deta Nonoate
- Deta/No
- Mehr Synonyme anzeigen
- Diethylamine NONOate
- Diethylamine diazeniumdiolate
- Diethylenetriamine Nonoate
- Ethanamine, 2,2′-(2-hydroxy-2-nitrosohydrazinylidene)bis-
- Ethanamine, 2,2′-(hydroxynitrosohydrazono)bis-
- NOC 18
Detanonoate is a cyclase inhibitor that can induce apoptosis and inhibit the production of pro-inflammatory cytokines. Detanonoate has been shown to be minimally toxic in cell culture studies and to have a minimal effect on enzyme activity. Detanonoate also has significant cytotoxicity against tumor cells, with minimal toxicity against normal cells. It also exerts an anti-inflammatory effect through its inhibition of toll-like receptor 4, which is involved in the inflammatory response. Detanonoate has been shown to decrease tumor growth by inhibiting matrix metalloproteinase-9 (MMP-9) activity, which may be due to its ability to inhibit mitochondrial membrane potential. Detanonoate is used for the treatment of bowel disease.
Chemische Eigenschaften
Technische Anfrage zu: 3D-FD16348 Detanonoate
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.